🇲🇹 Country Profile

Malta

Fast-growing pharmaceutical trade with Malta

🇲🇹 $285M

Dual-source profile. Both series show HS Chapter 30 (finished pharmaceutical products) aligned to calendar year (Jan–Dec). Eurostat records what Malta imports from India. DGCIS records what India exports to Malta. Category and product detail from DGCIS.

$285M

Scale

Malta's patients receive $285M in Indian pharmaceutical products annually — almost entirely finished medicines ready for dispensing.

95%

Medicine

Overwhelmingly finished medicines — drug formulations account for 95% of shipments.

5.2×

Trajectory

Rapid expansion: Malta's imports of Indian pharmaceutical products have grown 5.2× over the past decade, from $54.3M to $285M.

Context

Part of India's pharmaceutical supply network across Europe.

✦

Impact

Indian pharmaceutical companies have both exported to and invested directly in Malta — building trade and operational presence.

Non-Chapter-30 pharma categories from DGCIS (487-code basket)

Medicines $315M (95.2%) Medicine Ingredients $15.8M (4.8%) Surgical & Hospital Supplies $0.05M (0.0%) Traditional & Herbal $0.02M (0.0%)

Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $15.0M in active pharmaceutical ingredients and bulk drugs to Malta in 2025 (India-reported, DGCIS).

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Malta: $26.4M across 12 filings (2014-2026).